Distribution of sialic acid-dependent carbohydrate epitope in thyroid tumors: Immunoreactivity of FB21 in paraffin-embedded tissue sections

Pathology International

Volumn 49, Issue 5, 1999, Pages 403-407

  Nozawa, Yoshihiro ^a,b   Ami, Hirofumi ^b   Suzuki, Shinnichi ^b   Tuchiya, Atuo ^b   Abe, Rikiya ^c   Abe, Masafumi ^a  

^a Department of Pathology ^*  (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c National Hospital Organization   (Japan)

Author keywords

Carbohydrate; Follicular adenoma; Follicular carcinoma; Sialic acid; Thyroid

Indexed keywords

CARBOHYDRATE; EPITOPE; SIALIC ACID;

ANAPLASTIC CARCINOMA; ANTIGEN BINDING; ARTICLE; GOITER; GRAVES DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID TUMOR;

ADENOMA; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CARCINOMA; EPITOPES; GOITER; HUMANS; IMMUNOHISTOCHEMISTRY; N-ACETYLNEURAMINIC ACID; PARAFFIN EMBEDDING; PREDICTIVE VALUE OF TESTS; THYROID NEOPLASMS;

EID: 0033052617     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.1999.00884.x     Document Type: Article

References (17)

1. 1 Dennis JW, Laferte S. Tumor cell surface carbohydrate and the metastatic phenotype. Cancer Metastasis Rev. 1987; 5: 185-204.
2. Bernacki RJ. Concomitant elevations in serum sialyltransferase activity and sialic acid content in rats with metastasizing mammary tumors. Science 1977; 195: 577-579.
3. 3 Silver HKB, Karim KA, Archibald EL, Salinas FA. Serum sialic acid and sialyltransferase as monitors of tumor burden in malignant melanoma patients. Cancer Res. 1979; 39: 5036-5042.
4. 4 Fogel M, Altevogt P, Schirrmacher V. Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation. J. Exp. Med. 1983; 157: 371-376.
5. 5 Collard JG, Schijven JF, Bikker A et al. Cell surface sialic acid and the invasive and metastatic potential of T-cell hybridomas. Cancer Res. 1986; 46: 3521-3527.
6. 6 Gonzales-Campora R, Gallego FS, Lacave IM. Lectin histochemistry of the thyroid gland. Cancer 1988; 62: 2354-2362.
7. 7 Sobrinho-Simoes M, Damjanov I. Lectin histochemistry of papillary and follicular carcinoma of the thyroid gland. Arch. Pathol. Lab. Med. 1986; 110: 722-729.
8. 8 Ghali VS, Jimenez EJS, Garcia RL. Distribution of Leu-7 antigen (HNK-1) in thyroid tumors: Its usefulness as a diagnostic marker for follicular and papillary carcinomas. Hum. Pathol. 1992; 23: 21-25.
9. 9 Vierbuchen M, Schröder S, Uhlenbruck G, Ortmann M, Fischer R. CA50 and CA19-9 antigen expression in normal, hyperplastic, and neoplastic thyroid tissue. Lab. Invest. 1989; 60: 726-732.
10. 10 Nozawa Y, Abe M, Ohno H, Fukuhara S, Wakasa H. Production of two monoclonal antibodies (FB1 and FB21) useful for the identification of human B lymphocytes in formalin-fixed, paraffin-embedded tissues. J. Pathol. 1994; 173: 347-354.
11. 11 Schwartz-Albiez R, Moldenhauer G, Kuipers J, Möller P, Funderud S, Bast B. CDw75, CD76-, and other B-cell-associated carbohydrate epitopes. In: Schlossman SF, Boumsell L, Gilks W et al., eds. Leucocyte Typing V. Oxford University Press, Oxford, 1995; 580-586.
12. 12 Silverberg SG, Vidone RA. Adenoma and carcinoma of the thyroid. Cancer 1966; 19: 1053-1062.
13. 13 Hirai K, Kotani T, Aratake Y, Ohtaki S, Kuma K. Dipeptidyl peptidase IV (DPP IV/CD26) staining predicts distant metastasis of benign thyroid tumor. Pathol. Int. 1999; (in press).
14. 14 Hedinger C, Williams ED, Sobin LH. International Histological Classification of Tumors. Histological Typing of Thyroid Tumors (2nd ed.) Springer-Verlag, Berlin, 1988.
15. 15 Lang W, Georgii A, Stauch G et al. The differentiation of atypical adenomas and encapsulated follicular carcinomas in the thyroid gland. Virchows Arch. A Pathol. Anat. Histopathol. 1980; 385: 125-141.
16. 16 Loy TS, Darkow GV, Spollen LE, Diaz-Arias AA. Immunostaining for Leu-7 in the diagnosis of thyroid carcinoma. Arch. Pathol. Lab Med. 1994; 118: 172-174.
17. 17 Sack MJ, Astengo-Osuna C, Lin BTY, Battifora H, LiVolsi VA. HBME-1 immunostaining in thyroid fine-needle aspirations: A useful marker in the diagnosis of carcinoma. Mod. Pathol. 1997; 10: 668-674.